Company
CEO’s Message
History
About Us
R&D Center
Vision &
Core Values
Organization &
Research areas
Platform technology &
Research Pipeline
Patents and
Technology Certification
Contact for
research collaboration
Product
ETC / OTC
CMO
Updated Product
Information
ESG
EHS Management
Human resources
Governance
Customer
Customer
Consultation
ENG
KOR
ENG
CHN
Company
CEO’s Message
History
About Us
R&D Center
Vision &
Core Values
Organization &
Research areas
Platform technology &
Research Pipeline
Patents and
Technology Certification
Contact for
research collaboration
Product
ETC / OTC
CMO
Updated Product
Information
ESG
EHS Management
Human resources
Governance
Customer
Customer
Consultation
Company
CEO’s Message
History
About Us
R&D Center
Vision &
Core Values
Organization &
Research areas
Platform technology &
Research Pipeline
Patents and
Technology Certification
Contact for
research collaboration
Product
ETC / OTC
CMO
Updated Product
Information
ESG
EHS Management
Human resources
Governance
Customer
Customer
Consultation
Product
HLB PHARMA
Company
CEO’s Message
History
About Us
R&D Center
Vision &
Core Values
Organization &
Research areas
Platform technology &
Research Pipeline
Patents and
Technology Certification
Contact for
research collaboration
Product
ETC / OTC
CMO
Updated Product
Information
ESG
EHS Management
Human resources
Governance
Customer
Customer
Consultation
OTC
Product
General Pharmaceutical
Products
OTC
219 Other Circulatory System Drug
L-Queen Tab.
Product Type
OTC
Insurance Code
Uninsured
Insurance Drug Price
-
Important Information
Precautions
Product Counseling
Component / Content
L-Carnitine 330mg in each tablet
Efficacy
1. Primary and secondary systemic carnitine deficiency
2. Myocardial metabolic disorder due to ischemic heart disease : angina pectoris, acute myocardial infarction
Usage / Capacity
Adults : take 2~3g of L-Carnitine 2~3 times in divided dose a day.
The dosage may be adjusted according to the patient
,
s age and symptoms
Packing
90T(PTP)
∗
This is a required detail.
product name
∗
Name
∗
Contact
∗
Direct input
010
011
016
017
018
019
-
-
E-mail
@
Direct input
Hanmail
Naver
Nate
Korea
Hana Force
Gmail
MSN
Neptune
Yahoo
Empas
Clairvoyance
Hotmail
E-mail Acceptance
∗
Receive Agreement
Denial
Title
∗
Contents
∗
Attachments
※he size of attached files should be less than 3M..
On a list
Company
CEO’s Message
History
About Us
R&D Center
Vision &
Core Values
Organization &
Research areas
Platform technology &
Research Pipeline
Patents and
Technology Certification
Contact for
research collaboration
Product
ETC / OTC
CMO
Updated Product
Information
ESG
EHS Management
Human resources
Governance
Customer
Customer
Consultation